Precipio & ADS Biotec Launch Seven Beta sites for IV-Cell™
October 06, 2020 10:00 ET
|
Precipio, Inc.
NEW HAVEN, Conn., Oct. 06, 2020 (GLOBE NEWSWIRE) -- Specialty cancer diagnostics company Precipio, Inc. (NASDAQ: PRPO), along with its partner ADS Biotec announce the launch of the beta phase...